Nevertheless, there are few research studies on the comprehensive analysis of SLC2A1 in CRC, particularly the relation between SLC2A1 and immune therapy, m6A modification, ferroptosis, and ceRNA regulatory network of CRC. The gene discussed is SLC2A1; the disease is colorectal carcinoma.